A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

NCT05890729 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Sarcoidosis

Interventions

DRUG: XTMAB-16 or Placebo

Sponsor

Xentria, Inc.